This stock has horrifically bad spreads, i usually stay away from trash like this but reviewing trading data from this month i'm seeing extremely big activity behind this stock. I also checked around and apparently Jim Cramer is bearish this stock within the same month as said same extremely trading activity. Due to these nice 2 conflicting things i've gone ahead...
Diagonal double bottom along strong downtrend line This double bottom may push price up within this falling wedge structure I have plotted If it breaks the upper line further increases may be seen
We have retraced the complete decline since 10th February. As the overall trend remains bearish we may expect a further fall now. At 2 there is a major resistance level now.
Long-term, perfect buy setup. Impulse as a leading diagonal, correction as a flat. Wave 3 is likely an extended one. Good luck!
This is a simple setup- it feels like a 50% retracement from the recent high Technicals 1) the trend line was crossed 2) the moving average crossed below and has stayed there for a few days Targeting a move to S1 ($27) - approx. a 15% move from today's close ($31)
First the divergence will push the price to the last resistance test then the price will soar to surprising levels thanks to bullish psychology and price action
Hey guys, BAUSCH HEALTH COMPANIES is in a bullish configuration with a hammer candle shape and past buy volume return. Looking at the TIMEFRAME M1 we see a kind of hammer candle with a large volume of purchases traded, it has come to test the lowest bollinger. And start again on its highest which is the test of the consolidation zone. There is a good chance of...
If the price close above 20$, the target is 23$. This situation can be before break out. You may want to pay attention.
Aug-21st, $18 Call Strike = 0.30 38000 Volume and 9000 Open Interest
After being downtrending for the last couple of years and market putting in a bottom. See this stock going up much higher and expecting some news about their product on Lucentis biosimilar Risk Score: 8 out of 10 investment: Quarterly Holding
BHC: Bausch Health Companies Inc. 2020-04-29 07:00:00 FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old
on the verge of breaking out. Long accumulation is ending